BETR ACQUIRES LICENSE TO HUDDLE TECH SPORTS GAMING TECHNOLOGY
Betr bolsters its content and technology capabilities and fully vertically integrates product
Betr has already integrated Huddle Tech's software in its new sportsbook platform, which remains on track to launch ahead of the 2024 NFL season. The new Betr Sportsbook will initially launch in
"We expect this transaction to be transformative for Betr, as we now have accelerated our product roadmap by years, have vertically integrated our product and therefore have further improved an already strong gross margin profile for our business, and will be more advanced or at least on par from a sports gaming content standpoint than our competitors," said
"We are thrilled to see Betr utilize our software technology to enhance their sports gaming offerings," said
About Huddle
Huddle is a next-generation technology provider building advanced, proprietary data-driven solutions designed to transform the user experience and unlock the true potential of iGaming operators. By combining infrastructure that collects and organizes disparate data sets in near real-time and proprietary algorithms developed by some of the brightest minds in the industry, Huddle provides best-in-class solutions for gaming operators while creating cost-saving operational efficiencies. Huddle's solution provides the automated pricing of basketball, football, tennis, ice hockey, and baseball, both pre-match and in-play.
About Betr
Founded in 2022 by
For more information on Betr, visit betr.app or follow @betr on TikTok, Instagram, and Twitter. To learn more about responsible play, please visit betr.app/responsibility.
View original content to download multimedia:https://www.prnewswire.com/news-releases/betr-acquires-license-to-huddle-tech-sports-gaming-technology-302228808.html
SOURCE Betr Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEXT PROPERTIES ANNOUNCES RESULTS OF EXCHANGE OFFERS FOR ANY & ALL OF ITS OUTSTANDING 6.950% SENIOR NOTES DUE 2044 AND 6.390% SENIOR NOTES DUE 2050 FOR ADDITIONAL 7.731% SENIOR SUSTAINABILITY-LINK
- Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026
- LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share